Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating and Adjusts Price Target for Phreesia NYSE PHR

Elaine Mendonca by Elaine Mendonca
January 18, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On January 18, 2024, Ryan MacDonald, an analyst at Needham, expressed his optimistic view on Phreesia (NYSE: PHR) by reiterating a Buy rating and maintaining a price target of $29. This reaffirmation of confidence in the company’s stock indicates the potential for upward movement. Although the price target has been adjusted from $40 to $29, the Buy recommendation showcases MacDonald’s belief in Phreesia’s future performance.

PHR Stock Performance Declines on January 18, 2024: A Detailed Analysis

PHR, a publicly traded company, experienced a decline in its stock performance on January 18, 2024. According to data sourced from CNN Money, the stock closed at $24.03, marking a decrease of $0.68 or 2.75% from the previous market close. Additionally, in after-hours trading, the stock dropped a further $0.20.

PHR Stock Performance on January 18, 2024: Mixed Revenue Growth and Net Income Decline

PHR Stock Performance on January 18, 2024: A Mixed Bag of Revenue Growth and Net Income Decline

On January 18, 2024, PHR stock experienced a mixed performance as the company’s revenue showed promising growth, while its net income declined.

Total revenue for PHR stood at $280.91 million for the past year, representing a substantial increase of 31.74% compared to the previous year. Additionally, the company’s total revenue also increased by 6.74% since the last quarter.

However, the picture is not entirely rosy, as PHR’s net income witnessed a decline. Over the past year, the company reported a net income of -$176.15 million, reflecting a decrease of 49.07% compared to the previous year. On a positive note, the net income increased by 13.13% since the last quarter.

The earnings per share (EPS) is another crucial metric to assess a company’s financial performance. PHR reported an EPS of -$3.36 for the past year, which is a decrease of 41.82% compared to the previous year. However, there was a slight improvement in the EPS since the last quarter, with a 15.42% increase.

Overall, the stock performance of PHR on January 18, 2024, showcased a mix of positive and negative indicators. While the company experienced significant revenue growth over the past year and quarter, the net income and EPS declined on a yearly basis. However, there was a slight improvement in net income and EPS since the last quarter, which may indicate that PHR is taking steps to address its profitability challenges.

Investors should carefully analyze these financial metrics and consider other factors, such as market conditions and industry trends, before making any investment decisions related to PHR stock. It is essential to assess the company’s long-term strategy, competitive positioning, and ability to adapt to changing market dynamics to make informed investment choices.

Tags: PHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Market Capitalization

Introducing Club92 Dollar Generals Exclusive Home Fragrance Collection

Technology Robotics Trading online

Analysts Provide Mixed Ratings and Price Targets for Impinj NASDAQPI

CTVA stock news

Mixed Analyst Sentiments and Price Targets for Adobe NASDAQ ADBE

Recommended

Eli Lilly Stock

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

3 months ago
Applovin Stock

Regulatory Storm Clouds Gather Over Applovin

4 months ago
Apple Stock

Berkshire’s Apple Share Sale Sparks Market Speculation Ahead of Key Launch

5 months ago
Asml Stock

Is ASML Stock Presenting a Major Buying Opportunity?

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Trending

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

by Jackson Burston
February 7, 2026
0

In late January 2026, ServiceNow reported quarterly financial results that surpassed even the most optimistic projections from...

Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com